Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 Sep;8(9):616-9.
doi: 10.1631/jzus.2007.B0616.

Amniotic membrane transplantation for porous sphere orbital implant exposure

Affiliations
Case Reports

Amniotic membrane transplantation for porous sphere orbital implant exposure

Yan-hong Chen et al. J Zhejiang Univ Sci B. 2007 Sep.

Abstract

Objective: This study is aimed at describing the clinical outcome of amniotic membrane transplantation for exposure of porous sphere implants.

Methods: A retrospective review of consecutive cases of porous sphere orbital implant exposure was carried out. Eight cases were presented between May 2004 and Oct. 2006 (5 males, 3 females; mean age 44.5 years). Six had enucleation and two had evisceration. Exposure occurred in two primary and six secondary. Orbital implant diameter was 22 mm in seven cases and 20 mm in one case. Six patients are with hydroxyapatite and two with high-density porous polyethylene (Medpor) orbital implants. The mean time from implantation to exposure was 1.1 months (range 0.8-2 months). All patients required surgical intervention.

Results: The time of follow-up ranged from 3.0 to 28.0 months (mean 16.5 months). Amniotic membrane grafting successfully closed the defect without re-exposure in all of these patients. The grafts were left bare with a mean time to conjunctiva of about 1 month (range 0.8-1.5 months).

Conclusion: Exposed porous sphere implants were treated successfully with amniotic membrane graft in all of patients. The graft is easy to harvest. This technique is useful, dose not lead to prolonged socket inflammation and infection, and it is valuable application extensively.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Buetiner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol. 1992;113(6):669–673. - PubMed
    1. Christmas NJ, Gordon CD, Murray TG, Tse D, Johnson T, Garonzil S, O′Brien JM. Intraorbital implants after enucleation and their complications: a 10-year review. Arch Ophthalmol. 1998;116(9):1199–1203. - PubMed
    1. Danz W. Mobility implants: a review. Adv Ophthalmic Plast Reconstr Surg. 1990;8:46–52. - PubMed
    1. Fan JT, Robertson DM. Long-term follow-up of the Allen implant, 1967 to 1991. Ophthalmology. 1995;102(3):510–516. - PubMed
    1. Inkster CF, Ng SG, Leatherbarrow B. Primary banked scleral patch graft in the prevention of exposure of hydroxyapatite orbital implants. Ophthalmology. 1994;109(2):398–392. - PubMed

Publication types